Cargando…

Public economic gains from tax-financed investments in childhood immunization in the United States

The emergence of COVID-19 has displayed the importance of immunization and the need for continued public investment in vaccination programs. Globally, national vaccination programs rely heavily on tax-financed expenditure, requiring upfront investments and ongoing financial commitments. To evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Connolly, Mark P., Kotsopoulos, Nikolaos, Roberts, Craig, Kotlikoff, Laurence, Bloom, David E., Hu, Tianyan, Nyaku, Mawuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584131/
https://www.ncbi.nlm.nih.gov/pubmed/37851624
http://dx.doi.org/10.1371/journal.pgph.0002461
_version_ 1785122686977966080
author Connolly, Mark P.
Kotsopoulos, Nikolaos
Roberts, Craig
Kotlikoff, Laurence
Bloom, David E.
Hu, Tianyan
Nyaku, Mawuli
author_facet Connolly, Mark P.
Kotsopoulos, Nikolaos
Roberts, Craig
Kotlikoff, Laurence
Bloom, David E.
Hu, Tianyan
Nyaku, Mawuli
author_sort Connolly, Mark P.
collection PubMed
description The emergence of COVID-19 has displayed the importance of immunization and the need for continued public investment in vaccination programs. Globally, national vaccination programs rely heavily on tax-financed expenditure, requiring upfront investments and ongoing financial commitments. To evaluate annual public investments, we conducted a fiscal analysis that quantifies the public economic consequences to government in the United States attributable to childhood vaccination. To estimate the change in net government revenue, we developed a decision-analytic model that quantifies lifetime tax revenues and transfers based on changes in morbidity and mortality arising from vaccination of the 2017 U.S. birth cohort. Reductions in deaths and comorbid conditions attributed to pediatric vaccines were used to derive gross lifetime earnings gains, tax revenue gains attributed to averted morbidity and mortality avoided, disability transfer cost savings, and averted special education costs associated with each vaccine. Our analysis indicates a fiscal dividend of $41.7 billion from vaccinating this cohort. The bulk of this gain for government reflects avoiding the loss of $30.6 billion in present-value tax revenues. All pediatric vaccines raise tax revenues by reducing vaccine-preventable morbidity and mortality in amounts ranging from $7.3 million (hepatitis A) to $20.3 billion (diphtheria) over the life course. Based on public investments in pediatric vaccines, a benefit-cost ratio of 17.8 was calculated for each dollar invested in childhood immunization. The public economic yield attributed to childhood vaccination in the U.S. is significant from a government perspective, providing fiscal justification for ongoing investment.
format Online
Article
Text
id pubmed-10584131
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-105841312023-10-19 Public economic gains from tax-financed investments in childhood immunization in the United States Connolly, Mark P. Kotsopoulos, Nikolaos Roberts, Craig Kotlikoff, Laurence Bloom, David E. Hu, Tianyan Nyaku, Mawuli PLOS Glob Public Health Research Article The emergence of COVID-19 has displayed the importance of immunization and the need for continued public investment in vaccination programs. Globally, national vaccination programs rely heavily on tax-financed expenditure, requiring upfront investments and ongoing financial commitments. To evaluate annual public investments, we conducted a fiscal analysis that quantifies the public economic consequences to government in the United States attributable to childhood vaccination. To estimate the change in net government revenue, we developed a decision-analytic model that quantifies lifetime tax revenues and transfers based on changes in morbidity and mortality arising from vaccination of the 2017 U.S. birth cohort. Reductions in deaths and comorbid conditions attributed to pediatric vaccines were used to derive gross lifetime earnings gains, tax revenue gains attributed to averted morbidity and mortality avoided, disability transfer cost savings, and averted special education costs associated with each vaccine. Our analysis indicates a fiscal dividend of $41.7 billion from vaccinating this cohort. The bulk of this gain for government reflects avoiding the loss of $30.6 billion in present-value tax revenues. All pediatric vaccines raise tax revenues by reducing vaccine-preventable morbidity and mortality in amounts ranging from $7.3 million (hepatitis A) to $20.3 billion (diphtheria) over the life course. Based on public investments in pediatric vaccines, a benefit-cost ratio of 17.8 was calculated for each dollar invested in childhood immunization. The public economic yield attributed to childhood vaccination in the U.S. is significant from a government perspective, providing fiscal justification for ongoing investment. Public Library of Science 2023-10-18 /pmc/articles/PMC10584131/ /pubmed/37851624 http://dx.doi.org/10.1371/journal.pgph.0002461 Text en © 2023 Connolly et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Connolly, Mark P.
Kotsopoulos, Nikolaos
Roberts, Craig
Kotlikoff, Laurence
Bloom, David E.
Hu, Tianyan
Nyaku, Mawuli
Public economic gains from tax-financed investments in childhood immunization in the United States
title Public economic gains from tax-financed investments in childhood immunization in the United States
title_full Public economic gains from tax-financed investments in childhood immunization in the United States
title_fullStr Public economic gains from tax-financed investments in childhood immunization in the United States
title_full_unstemmed Public economic gains from tax-financed investments in childhood immunization in the United States
title_short Public economic gains from tax-financed investments in childhood immunization in the United States
title_sort public economic gains from tax-financed investments in childhood immunization in the united states
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584131/
https://www.ncbi.nlm.nih.gov/pubmed/37851624
http://dx.doi.org/10.1371/journal.pgph.0002461
work_keys_str_mv AT connollymarkp publiceconomicgainsfromtaxfinancedinvestmentsinchildhoodimmunizationintheunitedstates
AT kotsopoulosnikolaos publiceconomicgainsfromtaxfinancedinvestmentsinchildhoodimmunizationintheunitedstates
AT robertscraig publiceconomicgainsfromtaxfinancedinvestmentsinchildhoodimmunizationintheunitedstates
AT kotlikofflaurence publiceconomicgainsfromtaxfinancedinvestmentsinchildhoodimmunizationintheunitedstates
AT bloomdavide publiceconomicgainsfromtaxfinancedinvestmentsinchildhoodimmunizationintheunitedstates
AT hutianyan publiceconomicgainsfromtaxfinancedinvestmentsinchildhoodimmunizationintheunitedstates
AT nyakumawuli publiceconomicgainsfromtaxfinancedinvestmentsinchildhoodimmunizationintheunitedstates